Amanda Davis, CRNP

NPI: 1619413275
Total Payments
$7,674
2024 Payments
$2,331
Companies
30
Transactions
406
Medicare Patients
558
Medicare Billing
$46,582

Payment Breakdown by Category

Food & Beverage$7,600 (99.0%)
Education$74.25 (1.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $7,600 403 99.0%
Education $74.25 3 1.0%

Top Paying Companies

Company Total Records Latest Year
Salix Pharmaceuticals, a division of Bausch Health US, LLC $1,005 56 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $1,001 55 $0 (2024)
ABBVIE INC. $931.82 60 $0 (2024)
IRONWOOD PHARMACEUTICALS, INC $591.99 36 $0 (2024)
Janssen Biotech, Inc. $576.08 33 $0 (2024)
Phathom Pharmaceuticals, Inc. $351.81 10 $0 (2024)
Regeneron Healthcare Solutions, Inc. $338.18 14 $0 (2024)
GENZYME CORPORATION $332.07 15 $0 (2024)
EVOKE PHARMA, INC. $331.44 17 $0 (2024)
Gilead Sciences, Inc. $318.36 15 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,331 104 Phathom Pharmaceuticals, Inc. ($351.81)
2023 $1,741 90 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($385.92)
2022 $1,830 109 Takeda Pharmaceuticals U.S.A., Inc. ($303.26)
2021 $1,772 103 AbbVie Inc. ($455.76)

All Payment Transactions

406 individual payment records from CMS Open Payments — Page 1 of 17

Date Company Product Nature Form Amount Type
12/19/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $24.82 General
Category: Immunology
12/11/2024 QOL Medical, LLC SUCRAID (Drug) Food and Beverage Cash or cash equivalent $29.81 General
Category: THERAPY FOR CSID
12/09/2024 Takeda Pharmaceuticals U.S.A., Inc. EOHILIA (Drug) Food and Beverage In-kind items and services $28.82 General
Category: INTERNAL MEDICINE
12/04/2024 EVOKE PHARMA, INC. GIMOTI (Drug) Food and Beverage In-kind items and services $21.12 General
Category: Gastroenterology
12/03/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $22.03 General
Category: Immunology
11/26/2024 IRONWOOD PHARMACEUTICALS, INC Linzess (Drug) Food and Beverage Cash or cash equivalent $23.72 General
Category: GI
11/20/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $14.02 General
Category: Gastroenterology
11/18/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $16.68 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
11/15/2024 AIMMUNE THERAPEUTICS, INC. ZENPEP (Drug) Food and Beverage In-kind items and services $22.63 General
Category: ENDOCRINE PANCREATIC INSUFFICIENCY
11/14/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $24.06 General
Category: GASTROENTEROLOGY
11/11/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $20.99 General
Category: Immunology
11/06/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $21.68 General
11/06/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $20.02 General
Category: GASTROENTEROLOGY
11/05/2024 EVOKE PHARMA, INC. GIMOTI (Drug) Food and Beverage In-kind items and services $21.59 General
Category: Gastroenterology
11/04/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $20.57 General
Category: INTERNAL MEDICINE
10/31/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC TRULANCE (Drug) Food and Beverage In-kind items and services $18.39 General
Category: Gastroenterology
10/30/2024 QOL Medical, LLC SUCRAID (Drug) Food and Beverage Cash or cash equivalent $25.57 General
Category: THERAPY FOR CSID
10/29/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $17.64 General
Category: INFLAMMATION AND IMMUNOLOGY
10/23/2024 EVOKE PHARMA, INC. GIMOTI (Drug) Food and Beverage In-kind items and services $14.90 General
Category: Gastroenterology
10/16/2024 Celltrion USA Inc. ZYMFENTRA (Biological) Food and Beverage In-kind items and services $23.76 General
Category: GASTROENTEROLOGY
10/16/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $20.60 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
10/14/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $19.87 General
Category: Immunology
10/09/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $16.94 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
10/08/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $26.27 General
Category: GASTROENTEROLOGY
10/03/2024 QOL Medical, LLC SUCRAID (Drug) Food and Beverage Cash or cash equivalent $26.38 General
Category: THERAPY FOR CSID

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 177 206 $79,361 $15,683
2022 3 146 160 $63,215 $12,523
2021 3 137 150 $58,516 $12,075
2020 3 98 103 $21,638 $6,301
Total Patients
558
Total Services
619
Medicare Billing
$46,582
Procedure Codes
12

All Medicare Procedures & Services

12 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 97 124 $43,152 $8,837 20.5%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 55 55 $29,810 $5,481 18.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 25 27 $6,399 $1,364 21.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 71 85 $29,580 $6,398 21.6%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 52 52 $28,184 $5,037 17.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 23 23 $5,451 $1,089 20.0%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 73 86 $29,928 $6,720 22.5%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 44 44 $23,848 $4,432 18.6%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 20 20 $4,740 $923.68 19.5%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 30 30 $8,920 $2,946 33.0%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 37 38 $8,797 $1,859 21.1%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 31 35 $3,921 $1,497 38.2%

About Amanda Davis, CRNP

Amanda Davis, CRNP is a Family healthcare provider based in Helena, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/06/2017. The National Provider Identifier (NPI) number assigned to this provider is 1619413275.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amanda Davis, CRNP has received a total of $7,674 in payments from pharmaceutical and medical device companies, with $2,331 received in 2024. These payments were reported across 406 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($7,600).

As a Medicare-enrolled provider, Davis has provided services to 558 Medicare beneficiaries, totaling 619 services with total Medicare billing of $46,582. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.

Practice Information

  • Specialty Family
  • Location Helena, AL
  • Active Since 01/06/2017
  • Last Updated 07/21/2017
  • Taxonomy Code 363LF0000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1619413275

Products in Payments

  • ENTYVIO (Biological) $905.61
  • DUPIXENT (Biological) $670.25
  • Linzess (Drug) $591.99
  • XIFAXAN (Drug) $568.24
  • STELARA (Biological) $535.22
  • LINZESS (Drug) $456.85
  • TRULANCE (Drug) $436.76
  • VOQUEZNA (Drug) $351.81
  • GIMOTI (Drug) $331.44
  • IBSRELA (Drug) $309.34
  • CREON (Drug) $227.02
  • DIFICID (Drug) $211.14
  • SUCRAID (Drug) $207.16
  • MAVYRET (Drug) $190.00
  • ZEPOSIA (Drug) $181.95
  • XELJANZ (Drug) $138.77
  • ZENPEP (Drug) $96.06
  • Talicia (Drug) $69.12
  • MOTEGRITY (Drug) $66.75
  • VIBERZI (Drug) $57.95

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Doctors in Helena